Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription 30.04.2018 3 BMC Cancer 1 Cancer 1 Curr Treat Options Oncol 1 Eur J Cancer 10 Eur J Surg Oncol 7 Gastroenterology 2 Int J Cancer 1 Int J Colorectal Dis 2 Oncol Rep 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMC Cancer

1. BRONZWAER MES, Greuter MJE, Bleijenberg AGC, IJspeert JEG, et al
   Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening.
   BMC Cancer. 2018;18:465.
   PubMed     Text format     Abstract available
   
   
2. ARROSPIDE A, Idigoras I, Mar J, de Koning H, et al
   Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model.
   BMC Cancer. 2018;18:464.
   PubMed     Text format     Abstract available
   
   
3. MUNKER S, Gerken M, Fest P, Ott C, et al
   Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects.
   BMC Cancer. 2018;18:455.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

4. KARUTURI MS, Holmes HM, Lei X, Johnson M, et al
   Potentially inappropriate medication use in older patients with breast and colorectal cancer.
   Cancer. 2018 Apr 24. doi: 10.1002/cncr.31403.
   PubMed     Text format     Abstract available
   
   

   
   Curr Treat Options Oncol

5. LAM M, Loree JM, Pereira AAL, Chun YS, et al
   Correction to: Accelerating Therapeutic Development through Innovative Trial Design in Colorectal Cancer.
   Curr Treat Options Oncol. 2018;19:25.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Cancer

6. MARGALIT O, Mamtani R, Yang YX, Reiss KA, et al
   A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.
   Eur J Cancer. 2018;96:105-110.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Surg Oncol

7. HUISKENS J, Olthof PB, van der Stok EP, Bais T, et al
   Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison.
   Eur J Surg Oncol. 2018;44:108-114.
   PubMed     Text format     Abstract available
   
   
8. JONES HJS, Cunningham C, Nicholson GA, Hompes R, et al
   Outcomes following completion and salvage surgery for early rectal cancer: A systematic review.
   Eur J Surg Oncol. 2018;44:15-23.
   PubMed     Text format     Abstract available
   
   
9. SUTTON PA, Jithesh PV, Jones RP, Evans JP, et al
   Exome sequencing of synchronously resected primary colorectal tumours and colorectal liver metastases to inform oncosurgical management.
   Eur J Surg Oncol. 2018;44:115-121.
   PubMed     Text format     Abstract available
   
   
10. DUPRE A, Malik HZ, Jones RP, Diaz-Nieto R, et al
    Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:80-86.
    PubMed     Text format     Abstract available
    
    
11. LINTER KAPISINSKA M, Hovorkova E, Zavalova V, Subrt Z, et al
    Distribution of metastases in mesorectum is unpredictable: Metastases do not respect tumor localization even in small non-circumferential rectal cancers.
    Eur J Surg Oncol. 2018;44:87-92.
    PubMed     Text format     Abstract available
    
    
12. STIFT J, Graf A, Schwarz C, Tamandl D, et al
    Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:139-147.
    PubMed     Text format     Abstract available
    
    
13. OMICHI K, Shindoh J, Cloyd JM, Mizuno T, et al
    Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.
    Eur J Surg Oncol. 2018;44:122-129.
    PubMed     Text format     Abstract available
    
    
14. SAO JULIAO GP, Habr-Gama A, Vailati BB, Aguilar PB, et al
    Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    Eur J Surg Oncol. 2018;44:93-99.
    PubMed     Text format     Abstract available
    
    
15. WESTBERG K, Palmer G, Hjern F, Johansson H, et al
    Management and prognosis of locally recurrent rectal cancer - A national population-based study.
    Eur J Surg Oncol. 2018;44:100-107.
    PubMed     Text format     Abstract available
    
    
16. FALCAO D, Alexandrino H, Caetano Oliveira R, Martins J, et al
    Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival.
    Eur J Surg Oncol. 2018 Apr 11. pii: S0748-7983(18)30992.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

17. LI T, Hao CY, Zhang ZL
    Hematochezia Caused by a Colon Disease With Unusual Presentation.
    Gastroenterology. 2018;154:e1-e3.
    PubMed     Text format    
    
    
18. HSU MH, Chen YJ, Wang WL
    An Unusual Colon Cystic Tumor.
    Gastroenterology. 2018;154:1244-1245.
    PubMed     Text format    
    
    
19. OZAWA T, Kandimalla R, Gao F, Nozawa H, et al
    A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
    Gastroenterology. 2018;154:844-848.
    PubMed     Text format     Abstract available
    
    
20. HE X, Wu K, Ogino S, Giovannucci EL, et al
    Association between Risk Factors for Colorectal Cancer and Risk of Serrated Polyps and Conventional Adenomas.
    Gastroenterology. 2018 Apr 24. pii: S0016-5085(18)30480.
    PubMed     Text format     Abstract available
    
    
21. NAKATSU G, Zhou H, Wu WKK, Wong SH, et al
    Alterations in Enteric Virome Associate With Colorectal Cancer and Survival Outcomes.
    Gastroenterology. 2018 Apr 21. pii: S0016-5085(18)30479.
    PubMed     Text format     Abstract available
    
    
22. KNIELING F, Gonzales Menezes J, Claussen J, Schwarz M, et al
    Raster-Scanning Optoacoustic Mesoscopy for Gastrointestinal Imaging at High Resolution.
    Gastroenterology. 2018;154:807-809.
    PubMed     Text format    
    
    
23. SHARMA D, Malik A, Guy CS, Karki R, et al
    Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis.
    Gastroenterology. 2018;154:948-964.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

24. MURPHY N, Achaintre D, Zamora-Ros R, Jenab M, et al
    A Prospective Evaluation of Plasma Polyphenol Levels and Colon Cancer Risk.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31563.
    PubMed     Text format     Abstract available
    
    
25. CHEN L, Pan X, Hu X, Zhang YH, et al
    Gene expression differences among different MSI statuses in colorectal cancer.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31554.
    PubMed     Text format     Abstract available
    
    

    
    Int J Colorectal Dis

26. LANDRE T, Maillard E, Taleb C, Ghebriou D, et al
    Impact of the addition of bevacizumab, oxaliplatin, or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients.
    Int J Colorectal Dis. 2018 Apr 21. pii: 10.1007/s00384-018-3053.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

27. ALOWAIDI F, Hashimi SM, Alqurashi N, Alhulais R, et al
    Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6392.
    PubMed     Text format     Abstract available
    
    
28. TERASAKI M, Mima M, Kudoh S, Endo T, et al
    Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
    Oncol Rep. 2018 Apr 24. doi: 10.3892/or.2018.6398.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

29. PANDE M, Joon A, Brewster AM, Chen WV, et al
    Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
    PLoS One. 2018;13:e0196245.
    PubMed     Text format     Abstract available
    
    
30. LEE MK, Kim NK, Jeon JY
    Effect of the 6-week home-based exercise program on physical activity level and physical fitness in colorectal cancer survivors: A randomized controlled pilot study.
    PLoS One. 2018;13:e0196220.
    PubMed     Text format     Abstract available
    
    
31. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
    A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    PLoS One. 2018;13:e0192744.
    PubMed     Text format     Abstract available
    
    
32. MYTE R, Gylling B, Haggstrom J, Schneede J, et al
    One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
    PLoS One. 2018;13:e0196233.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: